Congratulations to our rising star resident, @ZaferAkmanMD, on winning the Best Abstract Award in Geriatric Cardiology at ACC26! 🏆
His work, Calcium Channel Blockers vs Beta Blockers and Risk of Cognitive Decline in Older Adults, highlights the importance of studying cardiovascular therapies with cognitive outcomes in mind, an area underscored by studies such as SPRINT-MIND and further advanced by our ongoing LIVEBETTER clinical trial.
@MichaelGNanna@DrDamluji@YaleCardiology@TonyGuangyuTONG@YaleIMed@TradIMYale #GeriatricCardiology #ACC26 @ACCinTouch
NOLA, here we come! 🌟
I’ll be presenting 3 abstracts at #ACC26! 🎉
🫀Excited to share our research on #HFpEF, #SCAD, and Resistant #HTN.
Grateful for the chance to contribute to this incredible conference!
#ACC2026#ACCWIC
Don’t miss the first official @CardioNerds 5K at #ACC2026
⏰ Sun March 29, 6:45 AM
🔗 Sign up here: https://t.co/R2EeN1Y7eI
Not a runner? No problem - walkers (like me!) are welcome! Come join us at the riverfront 🫀
Excited to share our new publication in @JACCJournals : Advances! 🎉
🫀Our meta-analysis shows aldosterone synthase inhibitors significantly reduce SBP in hypertension — but with higher risks of hyperkalemia, hyponatremia, and hypotension.
https://t.co/oAn7Hk6MCB
HeartWise Lab at #ACC26 🫀
Check out our full schedule! We're excited to share our latest work in cardiovascular prevention, aging, and real-world evidence.
Looking forward to seeing friends, collaborators, and meeting new colleagues in NOLA! ✨
#ACC26@ACCinTouch@heartwiselab@MichaelGNanna@DrDamluji